Open tender · Germany · Contract notice

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nitisinon, (OBO) ATC A16AX04 für die Zeit 01.03.2025 - 28.02.2027

DAK-Gesundheit

DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nitisinon, (OBO) ATC A16AX04 für die Zeit 01.03.2025…”. Bids close on 5 January 2027.

The work

Framework discount agreement for the active substance Nitisinon (ATC A16AX04) for the period 01.03.2025 - 28.02.2027.

  • Agreement is non-exclusive and allows for multiple partners
  • Contract documents must be submitted via email to openhouse@dak.de
  • Submission deadline is the 5th of the preceding month for the desired start date

Key facts

Contract period
01.03.2025 - 28.02.2027
Evaluation
Not a formal procurement procedure, but a framework agreement process.

What it takes to qualify

Worth a closer look

  • The tender document states it is not a formal procurement procedure and does not fall under cartel procurement law, but uses the form for open procedures.
  • The document mentions a link to download contract documents under 5.1.11, but the link itself is not provided in the text.

Policy conditions

No reservation, preference or local-content restriction.

Documents to submit

  1. AngebotsschreibenMust include declaration that no exclusion criteria under §§ 123 and 124 GWB apply.
  2. Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission of the contract with name or company stamp.
  3. Anlage 1 zum VertragFilled-out form to be submitted.
  4. Anlage 2 zum VertragExcel file listing the medicinal products.